BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
j b chemicals and pharma stock

J B CHEMICALS AND PHARMA Share Price

1824.35 9.65 (0.53%)
Dec 12 2024 01:24 PM Pharmaceuticals NSE: JBCHEPHARM

J B CHEMICALS AND PHARMA Share Price Update

As of the latest trading session, J B CHEMICALS AND PHARMA share price is currently at 1824.35, which is up by 9.65 from its previous closing. Today, the stock has fluctuated between 1802.70 and 1833.00. Over the past year, J B CHEMICALS AND PHARMA has achieved a return of 24.29 %. In the last month alone, the return has been 1.95 %. Read More...

J B CHEMICALS AND PHARMA Performance

Day Range

Low1802.70 High1833.00
1823.95

52 Week Range

Low 1412.55 High 2030.00
1823.95

J B CHEMICALS AND PHARMA Share Price

1726

506943

JBCHEPHARM

img img img img
No Data Available

Open Price

1832.00

Prev. Close

1814.70

Volume (Shares)

215320.00

Total traded value

3927.32

Upper Circuit

2177.60

Lower Circuit

1451.80

Note: The current prices & values are delayed, Login to your account for live updates.

J B CHEMICALS AND PHARMA Fundamentals


(Standalone)

Market Cap (Cr) 28312.96
PE Ratio (TTM) 46.95
Book Value / Share 203.15
Beta 0.40
ROE 20.39%
EPS (TTM) 38.62
Dividend Yield 0.67%
Net Profit Qtr (Cr) 173.12

J B CHEMICALS AND PHARMA Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 955.76
Operating Expense 730.44
Net Profit 173.12
Net Profit Margin (%) 18.11
Earnings Per Share (EPS) 11.15
EBITDA 277.07
Effective Tax Rate (%) 26.08
Particulars JUN 2024 (Values in Cr)
Revenue 952.31
Operating Expense 723.26
Net Profit 173.23
Net Profit Margin (%) 18.19
Earnings Per Share (EPS) 11.16
EBITDA 278.54
Effective Tax Rate (%) 26.03
Particulars MAR 2024 (Values in Cr)
Revenue 809.20
Operating Expense 662.19
Net Profit 125.85
Net Profit Margin (%) 15.55
Earnings Per Share (EPS) 8.11
EBITDA 211.15
Effective Tax Rate (%) 22.84
Particulars DEC 2023 (Values in Cr)
Revenue 800.10
Operating Expense 630.30
Net Profit 127.92
Net Profit Margin (%) 15.98
Earnings Per Share (EPS) 8.25
EBITDA 221.30
Effective Tax Rate (%) 27.48
Particulars SEP 2023 (Values in Cr)
Revenue 836.76
Operating Expense 642.88
Net Profit 145.02
Net Profit Margin (%) 17.33
Earnings Per Share (EPS) 9.36
EBITDA 241.68
Effective Tax Rate (%) 27.75
Particulars MAR 2024 (Values in Cr)
Revenue 3298.64
Operating Expense 2594.98
Net Profit 543.36
Net Profit Margin (%) 16.47
Earnings Per Share (EPS) 35.07
EBITDA 914.10
Effective Tax Rate (%) 26.40
Particulars MAR 2023 (Values in Cr)
Revenue 2884.16
Operating Expense 2365.77
Net Profit 388.89
Net Profit Margin (%) 13.48
Earnings Per Share (EPS) 50.29
EBITDA 673.33
Effective Tax Rate (%) 26.21
Particulars MAR 2022 (Values in Cr)
Revenue 2189.88
Operating Expense 1757.20
Net Profit 361.00
Net Profit Margin (%) 16.48
Earnings Per Share (EPS) 46.71
EBITDA 547.52
Effective Tax Rate (%) 23.40
Particulars MAR 2021 (Values in Cr)
Revenue 1892.00
Operating Expense 1410.18
Net Profit 447.08
Net Profit Margin (%) 23.63
Earnings Per Share (EPS) 57.85
EBITDA 668.26
Effective Tax Rate (%) 24.69
Particulars MAR 2020 (Values in Cr)
Revenue 1640.74
Operating Expense 1340.53
Net Profit 268.14
Net Profit Margin (%) 16.34
Earnings Per Share (EPS) 33.70
EBITDA 407.59
Effective Tax Rate (%) 21.03
Particulars MAR 2024 (Values in Cr)
Book Value / Share 188.36
ROE % 20.45
ROCE % 24.90
Total Debt to Total Equity 0.18
EBITDA Margin 26.81
Particulars MAR 2023 (Values in Cr)
Book Value / Share 320.55
ROE % 17.77
ROCE % 22.41
Total Debt to Total Equity 0.14
EBITDA Margin 22.41
Particulars MAR 2022 (Values in Cr)
Book Value / Share 276.15
ROE % 19.58
ROCE % 25.01
Total Debt to Total Equity 0.03
EBITDA Margin 24.04
Particulars MAR 2021 (Values in Cr)
Book Value / Share 234.17
ROE % 24.75
ROCE % 32.32
Total Debt to Total Equity 0.02
EBITDA Margin 29.88
Particulars MAR 2020 (Values in Cr)
Book Value / Share 185.75
ROE % 18.68
ROCE % 23.51
Total Debt to Total Equity 0.02
EBITDA Margin 23.57
Particulars MAR 2024 (Values in Cr)
Book Value / Share 185.98
ROE % 20.39
ROCE % 24.83
Total Debt to Total Equity 0.17
EBITDA Margin 27.71
Particulars MAR 2023 (Values in Cr)
Book Value / Share 315.65
ROE % 17.11
ROCE % 21.68
Total Debt to Total Equity 0.13
EBITDA Margin 23.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 272.21
ROE % 18.46
ROCE % 23.61
Total Debt to Total Equity 0.02
EBITDA Margin 25.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 233.75
ROE % 24.61
ROCE % 32.13
Total Debt to Total Equity 0.02
EBITDA Margin 32.02
Particulars MAR 2020 (Values in Cr)
Book Value / Share 187.02
ROE % 18.30
ROCE % 22.78
Total Debt to Total Equity 0.02
EBITDA Margin 24.84
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 95.53
Total Assets 3994.12
Total Liabilities 3994.12
Total Equity 2923.32
Share Outstanding 155194800
Price to Book Ratio 8.87
Return on Assets (%) 13.83
Return on Capital (%) 16.85
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 78.81
Total Assets 3553.87
Total Liabilities 3553.87
Total Equity 2480.35
Share Outstanding 77377584
Price to Book Ratio 6.24
Return on Assets (%) 11.53
Return on Capital (%) 13.53
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 58.52
Total Assets 2607.40
Total Liabilities 2607.40
Total Equity 2138.61
Share Outstanding 77282097
Price to Book Ratio 5.79
Return on Assets (%) 14.77
Return on Capital (%) 17.8
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 30.85
Total Assets 2238.11
Total Liabilities 2238.11
Total Equity 1813.42
Share Outstanding 77282097
Price to Book Ratio 5.36
Return on Assets (%) 20.01
Return on Capital (%) 24.27
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 30.94
Total Assets 1820.56
Total Liabilities 1820.56
Total Equity 1437.99
Share Outstanding 77282097
Price to Book Ratio 2.72
Return on Assets (%) 14.94
Return on Capital (%) 18.54
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 63.69
Total Assets 3913.63
Total Liabilities 3913.63
Total Equity 2886.26
Share Outstanding 155194800
Price to Book Ratio 8.87
Return on Assets (%) 13.88
Return on Capital (%) 16.83
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 55.76
Total Assets 3470.14
Total Liabilities 3470.14
Total Equity 2442.47
Share Outstanding 77377584
Price to Book Ratio 6.24
Return on Assets (%) 11.20
Return on Capital (%) 13.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 39.67
Total Assets 2538.06
Total Liabilities 2538.06
Total Equity 2103.66
Share Outstanding 77282097
Price to Book Ratio 5.79
Return on Assets (%) 14.22
Return on Capital (%) 16.95
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 26.42
Total Assets 2200.42
Total Liabilities 2200.42
Total Equity 1806.46
Share Outstanding 77282097
Price to Book Ratio 5.36
Return on Assets (%) 20.31
Return on Capital (%) 24.39
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 11.56
Total Assets 1811.43
Total Liabilities 1811.43
Total Equity 1445.29
Share Outstanding 77282097
Price to Book Ratio 2.72
Return on Assets (%) 14.80
Return on Capital (%) 18.18
Particulars MAR 2024 (Values in Cr)
Net Income 751.50
Cash from Operations 933.09
Cash from Investing -403.83
Cash from Financing -385.48
Net change in Cash 11.29
Free Cash Flow 1059.96
Particulars MAR 2023 (Values in Cr)
Net Income 555.23
Cash from Operations 721.09
Cash from Investing -961.78
Cash from Financing 356.53
Net change in Cash 20.36
Free Cash Flow 793.65
Particulars MAR 2022 (Values in Cr)
Net Income 504.90
Cash from Operations 304.75
Cash from Investing 2.31
Cash from Financing -138.38
Net change in Cash 34.06
Free Cash Flow 367.62
Particulars MAR 2021 (Values in Cr)
Net Income 596.88
Cash from Operations 456.50
Cash from Investing -230.67
Cash from Financing -87.42
Net change in Cash -3.31
Free Cash Flow 504.27
Particulars MAR 2020 (Values in Cr)
Net Income 348.89
Cash from Operations 366.54
Cash from Investing 23.92
Cash from Financing -306.05
Net change in Cash -6.37
Free Cash Flow 439.51
Particulars MAR 2024 (Values in Cr)
Net Income 738.33
Cash from Operations 916.96
Cash from Investing -412.44
Cash from Financing -374.07
Net change in Cash 2.50
Free Cash Flow 1043.07
Particulars MAR 2023 (Values in Cr)
Net Income 527.03
Cash from Operations 717.23
Cash from Investing -955.88
Cash from Financing 343.40
Net change in Cash 16.16
Free Cash Flow 789.69
Particulars MAR 2022 (Values in Cr)
Net Income 471.29
Cash from Operations 274.22
Cash from Investing 4.17
Cash from Financing -137.85
Net change in Cash 13.42
Free Cash Flow 335.51
Particulars MAR 2021 (Values in Cr)
Net Income 593.70
Cash from Operations 475.84
Cash from Investing -230.67
Cash from Financing -86.89
Net change in Cash 17.86
Free Cash Flow 523.15
Particulars MAR 2020 (Values in Cr)
Net Income 339.56
Cash from Operations 359.09
Cash from Investing 23.80
Cash from Financing -305.48
Net change in Cash -9.73
Free Cash Flow 430.82
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 37.45 3.55 499.34 37.54 / 77.70
BLISS GVS PHARMA LTD 151.80 19.00 1.58 1598.94 92.25 / 172.40
CIPLA LTD 1454.20 25.44 4.14 117443.01 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 410.00 142.36 4.15 1206.67 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 56.66 11.07 499.34 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.55 45.59 7.27 2167.00 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6595.05 128.08 24.26 16487.63 4050.15 / 8139.85
BLISS GVS PHARMA LTD 151.80 19.79 1.56 1598.94 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1797.60
  • 26 Days 1796.00
  • 10 Days 1782.20
  • 50 Days 1800.00
  • 12 Days 1779.30
  • 100 Days 1828.70
  • 20 Days 1768.70
  • 200 Days 1676.70
1814.25
PIVOT
First Resistance 1828.50
Second Resistance 1842.30
Third Resistance 1856.55
First Support 1800.45
Second Support 1786.20
Third Support 1772.40
RSI 54.84
MACD -16.69
Commodity Channel Index (CCI) 125.10
ADX 24.46
Williams % R -15.27

Over 1 Month

down

1.95

Over 3 Months

down

-2.84

Over 6 Months

down

-3.71

Over 1 Year

down

24.29

Over 3 Years

down

31.08

Over 5 Years

down

54.01

J B CHEMICALS AND PHARMA Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

J B CHEMICALS AND PHARMA Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
15.81
Promoter Holdings
53.73
FII
13.63
DII
16.81
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Tau Investment Holdings Pte. Ltd. Shareholding of Promoter and Promoter Group 8.3464664E7 53.74
Nippon Life India Trustee Ltd-a/c Nippon India Pharma Fund Public Shareholding 4649323.0 2.99
Axis Mutual Fund Trustee Limited A/c Axis Mutual Fund A/c Axis Small Cap Fund Public Shareholding 4370173.0 2.81
Kotak Emerging Equity Scheme Public Shareholding 2542339.0 1.64
Government Pension Fund Global Public Shareholding 2472312.0 1.59
Canara Robeco Mutual Fund A/c Canara Robeco Small Cap Fund Public Shareholding 1958253.0 1.26
Invesco India Contra Fund Public Shareholding 1859081.0 1.2

J B CHEMICALS AND PHARMA

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2024-02-16 5.5 Interim 2024-02-16 Equity shares 2023-08-17 9.25 Final 2023-08-17 Equity shares 2023-02-17 8.5 Interim 2023-02-18 Equity shares 2022-08-12 8.0 Final 2022-08-17 Equity shares 2022-02-23 8.5 Interim 2022-02-24 Equity shares 2021-09-01 8.0 Final 2021-09-02 Equity shares 2021-02-18 8.5 Interim 2021-02-22 Equity shares 2020-09-22 1.0 Final 2020-09-23 Equity shares 2020-03-03 10.0 Interim 2020-03-04 Equity shares 2019-08-14 5.0 Final 2019-08-16 Equity shares 2018-08-27 2.0 Final 2018-08-29 Equity shares 2017-09-11 1.0 Final 2017-09-13 Equity shares 2016-08-11 0.5 Final 2016-08-16 Equity shares 2016-03-17 4.5 Interim 2016-03-19 Equity shares 2015-08-06 10.0 Special 2015-08-08 Equity shares 2015-08-06 4.0 Final 2015-08-08 Equity shares 2014-09-04 3.0 Final 2014-09-06 Equity shares 2013-08-01 3.0 Final 2013-08-03 Equity shares 2012-07-19 1.0 Final 2012-07-21 Equity shares 2011-08-29 40.0 Interim 2011-08-31 Equity shares 2011-07-14 2.0 Final 2011-07-18 Equity shares 2010-07-15 2.0 Final 2010-07-19 Equity shares 2009-07-02 1.0 Final 2009-07-04 Equity shares 2008-07-03 0.5 Final 2008-07-05 Equity shares 2007-07-12 1.5 Final 2007-07-16 Equity shares 2006-11-13 1.1 Interim 0001-01-01 Equity shares
Ex-Date Ex-Bonus Ratio
1998-10-30 1998-10-05 1:1
Ex-Date Old FV NEW FV Record Date
2023-09-18 2.0 1.0 2023-09-18 2005-04-05 10.0 2.0 2005-04-12

Learn More About Stocks

About J B CHEMICALS AND PHARMA

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by J B CHEMICALS AND PHARMA

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of J B Chemicals & Pharmaceuticals Ltd?

Answer Field

The share price of J B Chemicals & Pharmaceuticals Ltd for NSE is ₹ 1824.35 and for BSE is ₹ 1821.5.

What is the Market Cap of J B Chemicals & Pharmaceuticals Ltd?

Answer Field

The market cap of J B Chemicals & Pharmaceuticals Ltd for NSE is ₹ 2,83,12.96 Cr. and for BSE is ₹ 2,82,68.73 Cr. as of now.

What is the 52 Week High and Low of J B Chemicals & Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of J B Chemicals & Pharmaceuticals Ltd for NSE is ₹ 2030.00 and ₹ 1412.55 and for BSE is ₹ 2029.00 and ₹ 1399.95.

How to Buy J B Chemicals & Pharmaceuticals Ltd share?

Answer Field

You can trade in J B Chemicals & Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for J B Chemicals & Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 24.29%.

What is the Current Share Price of J B Chemicals & Pharmaceuticals Ltd?

Answer Field

J B Chemicals & Pharmaceuticals Ltd share price is for NSE ₹ 1824.35 & for BSE ₹ 1821.5 as on Dec 12 2024 01:24 PM.

What is the Market Cap of J B Chemicals & Pharmaceuticals Ltd Share?

Answer Field

The market cap of J B Chemicals & Pharmaceuticals Ltd for NSE ₹ 2,83,12.96 & for BSE ₹ 2,82,68.73 as on Dec 12 2024 01:24 PM.

What is the P/E Ratio of J B Chemicals & Pharmaceuticals Ltd Share?

Answer Field

As on Dec 12 2024 01:24 PM the price-to-earnings (PE) ratio for J B Chemicals & Pharmaceuticals Ltd share is 46.95.

What is the PB ratio of J B Chemicals & Pharmaceuticals Ltd Share?

Answer Field

As on Dec 12 2024 01:24 PM, the price-to-book (PB) ratio for J B Chemicals & Pharmaceuticals Ltd share is 203.15.

How to Buy J B Chemicals & Pharmaceuticals Ltd Share?

Answer Field

You can trade in J B Chemicals & Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy J B Chemicals & Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy J B Chemicals & Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “J B Chemicals & Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader